XP-21279
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
XP-21279 is a sustained-release levodopa ( L -DOPA) prodrug and hence a dopamine precursor and non-selective dopamine receptor agonist which was under development for the treatment of Parkinson's disease. It is taken by mouth.
XP-21279 is a sustained-release levodopa ( L -DOPA) prodrug and hence a dopamine precursor and non-selective dopamine receptor agonist which was under development for the treatment of Parkinson's disease. It is taken by mouth.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1328672250 under CC BY-SA 4.0; modifications have been made.